PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsMutations in key gene drive malaria drug resistance

BioNews

Mutations in key gene drive malaria drug resistance

Published 26 January 2015 posted in News and appears in BioNews 787

Author

Dr Anna Cauldwell

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

The malaria parasite Plasmodium falciparum's resistance to artemisinin, one of the most effective antimalarial drugs, has been partially unravelled in a new Nature Genetics' study...

The resistance of the malaria parasite, Plasmodium falciparum, to artemisinin,
one of the most effective antimalarial drugs, has been partially unravelled in a Nature Genetics study.

The rapid rise of artemisinin resistance,
especially in South East Asia, is of growing concern and these new findings have
the potential to help health authorities predict the progress of future
outbreaks.

An international
team of scientists, led by Professor Dominic Kwiatkowski, of the University of Oxford and the Wellcome Trust
Sanger Institute, analysed 1,612
samples from 15 locations across South East Asia and Africa in a genome-wide
association study.

In particular, they
identified  20 mutations in the kelch13 gene which were associated with resistance to artemisinin treatment. While kelch13 is thought to be the most
important gene driving drug resistance, the scientists discovered that mutations
in kelch13 are more likely to emerge when
mutations in four other genes are present.

Dr Roberto Amato, first author on the paper, explained: 'Our
findings suggest that these background mutations emerged with limited impact on
artemisinin resistance - until mutations occurred in the kelch13 gene.'

'It's similar to
what we see with pre-cancerous cells that accumulate genetic changes but only
become malignant when they acquire critical driver mutations that kick off
growth.'

The scientists say
that the identification of background mutations is an important development. As
the number of kelch13 variants
associated with resistance continues to rise, it becomes increasingly difficult
to use this gene alone as a marker for genetic surveillance.

Now, researchers might
be able to monitor the genetic background in the hope of identifying parasite
populations most likely to become resistant.

Co-author Professor
Nick Day
, Director of the Mahidol-Oxford Tropical Medicine Research
Unit
 in Thailand, said: 'We
are at a pivotal point for malaria control. While malaria deaths have been
halved, this progress is at risk if artemisinin ceases to be effective. We need
to use every tool at our disposal to protect this drug. Monitoring parasites
for background mutations could provide an early warning system to identify
areas at risk for artemisinin resistance.'

Chloroquine, the first effective anti-malarial
drug, was introduced in the late 1940s. But chloroquine and several subsequent
treatments have been rendered useless in some parts of the world by the capacity of the malaria
parasite to develop resistance. Each time this has happened, the resistant
strains emerged in South East Asia.

Related Articles

PET BioNews
News
8 November 2019 • 2 minutes read

Cancer cells limit DNA repair to overcome treatment

by Dr Laura Riggall

Colorectal cancer cells increase the rate of mutations and impair DNA repair in their genomes to become more resistant to targeted therapies, a new study suggests...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
1 June 2017 • 2 minutes read

Resistance to severe malaria identified in gene variants

by Dr Molly Godfrey

A gene variant which gives protection against the most dangerous form of malaria has been identified...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
27 November 2015 • 3 minutes read

'Gene drive' could halt malaria transmission

by Ayala Ochert

Using 'gene drive' technology, scientists have created mosquitoes with malaria-resistant genes that could spread rapidly into wild mosquito populations, potentially wiping out the disease in some areas...

PET BioNews
News
5 December 2014 • 2 minutes read

Flu virus mutations leave vaccines ineffective

by Fiona Ibanichuka

The US Centers for Disease Control has released a health advisory warning clinicians that flu vaccines will have diminished effectiveness against one strain currently circulating in the US as it has mutated to become resistant...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
19 March 2013 • 2 minutes read

Mosquito gut bacteria genetically engineered to curb spread of malaria

by George Frodsham

Genetically modified bacteria may be a new weapon in the fight against malaria. Researchers have altered the genome of a bacterium that lives in mosquitos' guts so that it secretes proteins that are toxic to the malaria parasite...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 December 2012 • 1 minute read

Genome study suggests gene linked with cancer may be beneficial

by Dr Kimberley Bryon-Dodd

A study analysing three different, but closely related, African populations has identified that a cancer gene is present at a surprisingly high frequency; akin to those usually associated with evolutionary advantages...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
25 June 2010 • 2 minutes read

£25 million to study genetics of African diseases

by Ben Jones

The Wellcome Trust has joined forces with the US National Institute of Health (NIH) to coordinate a major new genetics study in Africa....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Stem cells partially reverse disability in small MS trial

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

5 July 2022 • 1 minute read

Anorexia in pregnancy linked to increased risk of complications

5 July 2022 • 2 minutes read

Pregnancy after breast cancer treatment does not increase risk of recurrence

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856